首页> 美国卫生研究院文献>Gastroenterology Research and Practice >Rectal Tumour Staging with Endorectal Ultrasound: Is There Any Difference between Western and Eastern European Countries?
【2h】

Rectal Tumour Staging with Endorectal Ultrasound: Is There Any Difference between Western and Eastern European Countries?

机译:直肠内直肠超声分期:西欧和东欧国家之间有区别吗?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background. Rectal tumour management depends highly on locoregional extension. Rectal endoscopic ultrasound (ERUS) is a good alternative to computed tomography and magnetic resonance imaging. However, in Hungary only a small amount of rectal tumours is examined with ERUS. Methods. Our retrospective study (2006–2012) evaluates the diagnostic accuracy of ERUS and compares the results, the first data from Central Europe, with those from Western Europe. The effect of neoadjuvant therapy, rectal probe type, and investigator's experience were also assessed. Results. 311 of the 647 ERUS assessed locoregional extension. Histological comparison was available in 177 cases: 67 patients underwent surgery alone; 110 received neoadjuvant chemoradiotherapy (CRT); ERUS preceded CRT in 77 and followed it in 33 patients. T-staging was accurate in 72% of primarily operated patients. N-staging was less accurate (62%). CRT impaired staging accuracy (64% and 59% for T- and N-staging). Rigid probes were more accurate (79%). At least 30 examinations are needed to master the technique. Conclusions. The sensitivity of ERUS complies with the literature. ERUS is easy to learn and more accurate in early stages but unnecessary for restaging after CRT. Staging accuracy is similar in Western and Central Europe, although the number of examinations should be increased.
机译:背景。直肠肿瘤的治疗在很大程度上取决于局部区域的扩展。直肠内窥镜超声检查(ERUS)是计算机断层扫描和磁共振成像的良好替代选择。但是,在匈牙利,仅用ERUS检查了少量的直肠肿瘤。方法。我们的回顾性研究(2006-2012年)评估了ERUS的诊断准确性,并将结果(中欧和西欧的第一批数据)进行了比较。还评估了新辅助治疗的效果,直肠探针的类型以及研究者的经验。结果。 647个ERUS中的311个评估了局部区域扩展。 177例可进行组织学比较:67例仅接受手术; 110例接受了新辅助放化疗(CRT); ERUS在CRT之前有77位患者,在33位患者之后。在72%的初次手术患者中,T分期是准确的。 N分期的准确性较差(62%)。 CRT损害了分级准确性(T和N分级分别为64%和59%)。刚性探头更准确(79%)。至少需要30考试才能掌握该技术。结论。 ERUS的敏感性符合文献。 ERUS易于学习,早期更准确,但对于CRT后的重新分期则不必要。西欧和中欧的分期准确性相似,尽管应增加检查次数。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号